Maxime Hoffmann

958 total citations
11 papers, 220 citations indexed

About

Maxime Hoffmann is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Nephrology. According to data from OpenAlex, Maxime Hoffmann has authored 11 papers receiving a total of 220 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 3 papers in Nephrology. Recurrent topics in Maxime Hoffmann's work include Vasculitis and related conditions (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers) and Metabolism and Genetic Disorders (2 papers). Maxime Hoffmann is often cited by papers focused on Vasculitis and related conditions (3 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers) and Metabolism and Genetic Disorders (2 papers). Maxime Hoffmann collaborates with scholars based in France. Maxime Hoffmann's co-authors include François Glowacki, David Buob, Christian Noël, Marie‐Christine Copin, Viviane Gnemmi, Raymond Azar, Marc Hazzan, Marie Frimat, Alexandre Seidowsky and Philippe Vanhille and has published in prestigious journals such as Kidney International, Journal of Investigative Dermatology and Transplantation.

In The Last Decade

Maxime Hoffmann

11 papers receiving 218 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maxime Hoffmann France	8	87	83	64	43	31	11	220
Jumpei Hasegawa Japan	8	28 0.3×	92 1.1×	42 0.7×	33 0.8×	17 0.5×	20	189
David Baird United Kingdom	6	79 0.9×	73 0.9×	31 0.5×	89 2.1×	7 0.2×	12	267
Yelena Drexler United States	9	72 0.8×	72 0.9×	19 0.3×	18 0.4×	7 0.2×	15	203
Weizhen Tan United States	8	190 2.2×	274 3.3×	120 1.9×	27 0.6×	7 0.2×	12	418
Amy Fearn United Kingdom	6	59 0.7×	128 1.5×	47 0.7×	9 0.2×	7 0.2×	6	229
Tuelay Kisner Germany	5	42 0.5×	79 1.0×	32 0.5×	9 0.2×	23 0.7×	8	349
Petr Vyleťal Czechia	9	152 1.7×	184 2.2×	94 1.5×	31 0.7×	4 0.1×	10	312
Katharina Artinger Austria	10	46 0.5×	78 0.9×	31 0.5×	20 0.5×	11 0.4×	21	274
Kendrah Kidd United States	8	109 1.3×	122 1.5×	64 1.0×	13 0.3×	3 0.1×	23	265
Shinya Ishiko Japan	11	195 2.2×	89 1.1×	44 0.7×	32 0.7×	3 0.1×	31	343

Countries citing papers authored by Maxime Hoffmann

Since Specialization

Citations

This map shows the geographic impact of Maxime Hoffmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxime Hoffmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxime Hoffmann more than expected).

Fields of papers citing papers by Maxime Hoffmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxime Hoffmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxime Hoffmann. The network helps show where Maxime Hoffmann may publish in the future.

Co-authorship network of co-authors of Maxime Hoffmann

This figure shows the co-authorship network connecting the top 25 collaborators of Maxime Hoffmann. A scholar is included among the top collaborators of Maxime Hoffmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxime Hoffmann. Maxime Hoffmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Gooderham, Melinda, Edward Lain, Yonghong Huang, et al.. (2025). LB1142 Phase 3 results from an innovative trial design of treating plaque psoriasis involving difficult-to-treat, high-impact sites with icotrokinra, a targeted oral peptide that selectively inhibits the IL-23–receptor. Journal of Investigative Dermatology. 145(8). S199–S199. 1 indexed citations

Bataille, Pierre, François Glowacki, Raymond Azar, et al.. (2019). Prognostic Value of Microscopic Hematuria after Induction of Remission in Antineutrophil Cytoplasmic Antibodies-Associated Vasculitis. American Journal of Nephrology. 49(6). 479–486. 16 indexed citations

Gibier, Jean‐Baptiste, Viviane Gnemmi, François Glowacki, et al.. (2017). Intratubular amyloid in light chain cast nephropathy is a risk factor for systemic light chain amyloidosis. Modern Pathology. 31(3). 452–462. 19 indexed citations

Buob, David, Viviane Gnemmi, Marie Frimat, et al.. (2016). Collapsing glomerulopathy is common in the setting of thrombotic microangiopathy of the native kidney. Kidney International. 90(6). 1321–1331. 49 indexed citations

Stehlé, Thomas, Dominique Joly, Philippe Vanhille, et al.. (2013). Clinicopathological study of glomerular diseases associated with sarcoidosis: a multicenter study. Orphanet Journal of Rare Diseases. 8(1). 65–65. 34 indexed citations

Seidowsky, Alexandre, Maxime Hoffmann, François Glowacki, et al.. (2012). Renal involvement in MELAS syndrome â a series of 5 cases and review of the literature. Clinical Nephrology. 80(12). 456–463. 44 indexed citations

Seidowsky, Alexandre, Maxime Hoffmann, Rafik Mesbah, et al.. (2007). Elastase-ANCA-associated idiopathic necrotizing crescentic glomerulonephritis--a report of three cases. Nephrology Dialysis Transplantation. 22(7). 2068–2071. 9 indexed citations

Hazzan, Marc, David Buob, Myriam Labalette, et al.. (2006). Assessment of the Risk of Chronic Allograft Dysfunction after Renal Transplantation in a Randomized Cyclosporine Withdrawal Trial. Transplantation. 82(5). 657–662. 26 indexed citations

Hoffmann, Maxime, et al.. (2005). Suivi néphrologique et niveau de prise en charge des patients en insuffisance rénale terminale. Néphrologie & Thérapeutique. 2(1). 15–23. 11 indexed citations

10.

Hoffmann, Maxime, et al.. (2004). [Acute renal failure and 2,8-dihydroxyadeninuria].. PubMed. 25(7). 297–300. 6 indexed citations

11.

Hoffmann, Maxime, et al.. (2002). Difficultés diagnostiques d’un thrombus de la crosse aortique. La Revue de Médecine Interne. 23(11). 943–947. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact